Snapshot
- LDV Mifa 9 electric MPV gets five-star ANCAP under 2022 criteria
- Does not apply to petrol LDV Mifa
- Third row only has child seat top tethers on the left side
The 2023 LDV Mifa 9, the brand's first electric passenger vehicle, has scored a five-star ANCAP safety rating under the 2022 testing criteria.
However, the crash rating only applies to the pure-electric Mifa 9 – instead of the identical petrol-powered Mifa.
ANCAP commended the three-row Mifa 9 as the only model besides the latest W206 Mercedes-Benz C-Class sedan to obtain maximum points for protecting the driver and small female rear passenger in the full-width frontal test.
But, the safety body warns that child seat restraints for younger children should not be fitted to the third-row centre or right-hand side seating positions as there are no top-tether anchor points. All second-row seats have top tethers, though.
The LDV Mifa 9 EV received 93 per cent adult occupant protection, 88 per cent child occupant protection, 73 per cent vulnerable road user protection, and 90 per cent in the safety assist category.
The Chinese-made electric people-mover is one of the last vehicles to be subject to ANCAP’s 2022 testing criteria, with stricter 2023 tests incoming that’ll assess floodwater submersion, systems that detect whether a child has been left behind in the vehicle, and car-to-motorcycle safety assist tests.
The 2023 LDV Mifa 9 starts from $106,000 before on-road costs. It comes with a centre airbag; front- and rear auto emergency braking; lane-keep assist; blind-spot monitoring; rear cross-traffic alert; door open warning; adaptive cruise control; traffic sign recognition; reversing camera and sensors as standard.
Opting for the mid-spec Executive variant adds front parking sensors and a 360-degree camera system.
The LDV Mifa and Mifa 9 act as the spiritual successor to the G10 family people-mover van – which only obtained a three-star ANCAP safety rating under the more lax 2025 testing criteria and will soon expire at the end of the year.
COMMENTS